Search

You searched for "outcome"

2549 results found

VISION 2020 LINKS: Retinoblastoma 
in Africa

1 October 2015 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
The VISION 2020 LINKS Programme is part of the ‘VISION 2020: The Right to Sight’ global initiative to eliminate avoidable blindness [1]. The LINKS Programme works with overseas eye departments to help identify priorities and match their priority needs with...

AOP calls for ‘bold thinking’ in response to DHSC request for new minor and urgent eyecare service

19 November 2023 | ICB, optometry, LOCSU, CCHEC, Adam Sampson
The development of a standard specification for ICBs is welcome but ambition for a national approach ‘should not be sacrificed’.

Act now: Professor Serge Resnikoff on making myopia a public health priority

3 April 2026 | | EYE - Paediatrics, EYE - Refractive
Over the past decade, myopia has shifted from a common childhood inconvenience to what global health leaders now call a “public health emergency in slow motion” [1]. According to Professor Serge Resnikoff, former Head of Eye Health at the World...

The future of glaucoma management: From sustained drug delivery to remote IOP monitoring

5 October 2026 | | EYE - Glaucoma
Glaucoma is a leading cause of irreversible vision loss worldwide, affecting millions around the globe [1]. Despite major advances in glaucoma treatment, complications of surgery and long-term disease management remain challenging due to poor adherence to topical medications, fluctuating intraocular...

Iris-claw IOL implantation: Indications, outcomes and complications

5 August 2026 | | EYE - Cataract, EYE - Refractive
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. A comprehensive study evaluating the clinical indications, visual outcomes and complication rates...

Outlook email tips

1 August 2019 |
Keeping on top of your work email can be quite a challenge in the context of a busy job. Below are a series of tips that you may find helpful in keeping your inbox at bay. The instructions and screenshots...

Heidelberg Engineering’s Tosh Vadhia announced as new ambassador for Orbis UK

2 January 2026 | charity, international, industry news
Tosh Vadhia, Head of Global Accounts at Heidelberg Engineering joins blindness prevention charity Orbis to help raise awareness of avoidable sight loss. Through Tosh Vadhia’s support, Heidelberg Engineering has played a key role in supporting Orbis’s mission to end avoidable...

My ophthalmic elective: focusing on myopia in Taiwan

3 June 2021 | | EYE - Cataract, EYE - Refractive, EYE - General
The authors describe their elective experience and delve further into high myopia, an emerging ophthalmic disease that is increasingly recognised in and outside Asia. The medical school elective programme presents an opportunity for students to conduct learning in their chosen...

Conference Report: RCOphth 2025

4 August 2025 | | Events, Meetings, Report, Royal College of Ophthalmologists, UK
This year’s Royal College of Ophthalmologists Annual Congress in Liverpool brought together eyecare professionals from across the country and beyond for four days of thought-provoking content, collaborative discussion and exciting glimpses into the future of ophthalmology. The opening day was...

Artificial intelligence in glaucoma: Assessing applications instead of technology

5 October 2026 | | EYE - Glaucoma
Much is said about the potential of artificial intelligence (AI) to transform clinical practice, particularly with the advent of foundation models [1]. The newest models are ‘pretrained’ on text, image, tabular and other forms of data to produce architectures that...

A closer look at the new wave of glaucoma surgery – radical or old school?

1 October 2016 | | EYE - Glaucoma
Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...

Management of diabetic macular oedema in vitrectomised eyes

1 August 2016 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is one of the leading causes of blindness; its prevalence is on the rise with progressive increase in numbers of people suffering from diabetes. The management of DMO has evolved significantly over the past few years....